TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31784929

Group type: EXPERIMENTAL
Intervention: PhotoBioModulation (PBM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP)
Number of subjects: 20
Study: 30285647

Group type: COMPARATOR
Intervention: Exposure to stressful life events (father's alcoholism)
Number of subjects: 1796

Group type: COMPARATOR
Intervention: Exposure to stressful life events (severe illness of a close family member)
Number of subjects: 1796

Group type: COMPARATOR
Intervention: Exposure to stressful life events (hospitalization of the child for another illness)
Number of subjects: 1796

Group type: COMPARATOR
Intervention: Exposure to stressful life events (being bullied at school)
Number of subjects: 1796

Group type: COMPARATOR
Intervention: Exposure to stressful life events (loss of a parent's job)
Number of subjects: 1796

Group type: COMPARATOR
Intervention: Symptoms associated with constipation (abdominal pain)
Number of subjects: 1796

Group type: COMPARATOR
Intervention: Symptoms associated with constipation (straining)
Number of subjects: 1796
Study: 26173463

Group type: EXPERIMENTAL
Intervention: Mandibular implant fixed partial prostheses (IFPP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mandibular implant-supported overdenture (ISOD)
Number of subjects: 48
Study: 23300117

Group type: EXPERIMENTAL
Intervention: golimumab 100 mg + MTX
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: golimumab 50 mg + MTX
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: golimumab + MTX
Number of subjects: 1081

Group type: COMPARATOR
Intervention: MTX-only
Number of subjects: 1081

Group type: COMPARATOR
Intervention: placebo + MTX
Number of subjects: 1081
Study: 22386826

Group type: EXPERIMENTAL
Intervention: 100 mg commercial sildenafil (reference)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 mg generic sildenafil (test 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 mg chewable generic sildenafil (test 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tolerability assessment
Number of subjects: 0
Study: 19656218

Group type: EXPERIMENTAL
Intervention: Traditional clamp with immediate post-pressing time for conventional heat-cure resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional clamp with 6-h post-pressing time for conventional heat-cure resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate post-pressing time for conventional heat-cure resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6-h delay in post-pressing time for rapid cycle heat-cure resin
Number of subjects: 0
Study: 18036005

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Trainee group
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Specialist group
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Specialist nurses
Number of subjects: 113
Study: 16195581

Group type: EXPERIMENTAL
Intervention: Milk fermented with Lactobacillus acidophilus strain L-92 (L-92), 100 ml, containing 5 x 10(10) bacteria, twice a day for 6 weeks
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Milk fermented with Lactobacillus acidophilus strain L-92 (L-92), daily dose of 2 x 10(10) bacteria for 10 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 23
Study: 12192847

Group type: EXPERIMENTAL
Intervention: Type A dressing
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Type B dressing
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Type C dressing
Number of subjects: 200
Study: 9475563

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg inhaled at bedtime followed by unblinded salmeterol 50 microg inhaled 12 hours later
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo inhaled at bedtime followed by unblinded salmeterol 50 microg inhaled 12 hours later
Number of subjects: 10
Study: 8713438

Group type: EXPERIMENTAL
Intervention: Pefloxacin (prophylactic)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pefloxacin (therapeutic)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pefloxacin
Number of subjects: 29
Study: 2704576

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intrauterine sounds intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 58
Study: 1082238

Group type: EXPERIMENTAL
Intervention: 200,000 IU of vitamin A every 4 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternate day dose of vitamin A in addition to massive therapy
Number of subjects: 0
Study: 30671591

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Running
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-Intensity Interval Cycling
Number of subjects: 20
Study: 29558290

Group type: EXPERIMENTAL
Intervention: Positive psychology intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 27155753

Group type: EXPERIMENTAL
Intervention: SFC group (25/50 μg b.i.d.)
Number of subjects: 128

Group type: COMPARATOR
Intervention: FP group (100 μg b.i.d.)
Number of subjects: 128
Study: 24481211

Group type: EXPERIMENTAL
Intervention: Bevacizumab nasal spray (25 mg/mL) at doses of 12.5, 25, 50, 75, and 100 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22258708

Group type: EXPERIMENTAL
Intervention: Single dose of vaccine with 15 μg hemagglutination antigen (HA)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Two doses of 15 μg HA
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Two doses of 30 μg HA
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Two doses of 15 μg HA for elderly
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Two doses of 30 μg HA for elderly
Number of subjects: 218
Study: 20638909

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ovarian stimulation for IVF
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Oral contraception
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dehydrogesterone for endometrial luteal phase defect
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Two different regimens of hormone replacement therapy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: No treatment
Number of subjects: 70

Group type: COMPARATOR
Intervention: Healthy fertile women (control group)
Number of subjects: 70
Study: 17998491

Group type: EXPERIMENTAL
Intervention: Strength training, aerobic, and flexibility exercise (ST)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Aerobic and flexibility exercise (AE)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Fibromyalgia Self‐Help Course (FSHC)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Combination of strength training and Fibromyalgia Self‐Help Course (ST-FSHC)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Exercise alone and in combination with education
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Progressive walking, simple strength training movements, and stretching activities
Number of subjects: 207
Study: 16330790

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (60 units)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 60
Study: 11971633

Group type: EXPERIMENTAL
Intervention: Forward version of liquid pouring from a beaker to a glass
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Forward versions of gravity-related events
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Separation events
Number of subjects: 7
Study: 10424549

Group type: EXPERIMENTAL
Intervention: Bioabsorbable interference screws (Bioscrew)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Metal interference screws
Number of subjects: 204
Study: 7489269

Group type: EXPERIMENTAL
Intervention: Polylactic acid granules
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control (no polylactic acid granules)
Number of subjects: 161
Study: 2268533

Group type: EXPERIMENTAL
Intervention: Concurrent intrathecal methotrexate therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: No concurrent intrathecal methotrexate therapy
Number of subjects: 70
Study: 367410

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30859382

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 120

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 120
Study: 28779582

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO₂) treatment
Number of subjects: 28
Study: 26228322

Group type: EXPERIMENTAL
Intervention: Single dose of cefuroxime sodium and metronidazole half-an-hour before induction (Group A)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Repeated dose of cefuroxime sodium and metronidazole postoperatively (Group B)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Single dose of cefuroxime sodium and metronidazole (Group A)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Repeated dose of cefuroxime sodium and metronidazole (Group B)
Number of subjects: 390
Study: 23987005

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 22619107

Group type: EXPERIMENTAL
Intervention: Sustained virological response (SVR) after PEG‐IFNα2a/RBV or PEG‐IFNα2b/RBV treatment
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Treatment failure (non-SVR)
Number of subjects: 431
Study: 19009225

Group type: EXPERIMENTAL
Intervention: 1-day catheter group
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 2-day catheter group
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: No catheter use group
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Short-term indwelling catheterization
Number of subjects: 150

Group type: COMPARATOR
Intervention: Overall findings
Number of subjects: 150
Study: 17519217

Group type: EXPERIMENTAL
Intervention: Oral psoralen‐UV‐A (PUVA) therapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Narrowband-UV-B (NB‐UVB) therapy
Number of subjects: 56
Study: 15385346

Group type: EXPERIMENTAL
Intervention: Peripherally inserted central catheters (PICCs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peripheral IV catheter (PIV)
Number of subjects: 0
Study: 11379362

Group type: EXPERIMENTAL
Intervention: Eradication treatment (pantoprazole 40 mg once daily, amoxycillin 100 mg b.i.d., clarithromycine 500 mg b.i.d.)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Eradication treatment
Number of subjects: 251
Study: 9685916

Group type: EXPERIMENTAL
Intervention: Soft gelatin capsule containing PEG 400 suspension of gliclazide
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diamicron (conventional tablet)
Number of subjects: 16
Study: 1559090

Group type: EXPERIMENTAL
Intervention: Immediate physiotherapy intervention by a physiotherapist
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Delayed physiotherapy intervention by a physiotherapist
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 94
Study: 2985658

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg tid increased to 100 mg tid)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg bid increased to 20 mg bid)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Methyldopa (250 mg to 500 mg bid and 1,000 mg bid)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Captopril and Enalapril (both groups)
Number of subjects: 20
Study: 30882578

Group type: EXPERIMENTAL
Intervention: Postoperative Radiation Therapy (PR group) with 150 mg/m/wk intra-arterial cisplatin for 4 weeks followed by radiotherapy
Number of subjects: 998

Group type: COMPARATOR
Intervention: Definitive Radiation Therapy (DR group) with 150 mg/m/wk intra-arterial cisplatin for 4 weeks followed by definitive radiotherapy
Number of subjects: 998
Study: 28597718

Group type: EXPERIMENTAL
Intervention: Adaptive running working memory training for 20 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study: 26943871

Group type: EXPERIMENTAL
Intervention: MIS-TLIF
Number of subjects: 97

Group type: COMPARATOR
Intervention: W-TLIF
Number of subjects: 97
Study: 24559178

Group type: EXPERIMENTAL
Intervention: Current Best Practices (CBP)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Current Best Practices (CBP) + Provider Performance Feedback (PF)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Current Best Practices (CBP) + Provider Performance Feedback (PF) + Pay-for-Performance (P4P)
Number of subjects: 18
Study: 22983924

Group type: EXPERIMENTAL
Intervention: Topiramate (maximum dose of 75 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 19159901

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: No thrombolytic therapy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 36
Study: 17882542

Group type: EXPERIMENTAL
Intervention: Negative discussions
Number of subjects: 114

Group type: COMPARATOR
Intervention: Positive interactions
Number of subjects: 114

Group type: COMPARATOR
Intervention: Neutral interactions
Number of subjects: 114
Study: 15036550

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg/d
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg/d
Number of subjects: 7

Group type: COMPARATOR
Intervention: Cocaine (0, 12, 25, and 50 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Gabapentin (0 mg/d)
Number of subjects: 7
Study: 11751775

Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of ceftazidime 1 g iv followed by a 4.5 g CI over 24 h
Number of subjects: 18

Group type: COMPARATOR
Intervention: 8-hourly administration of ceftazidime 1.5 g tds
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of ceftazidime
Number of subjects: 18
Study: 9664988

Group type: EXPERIMENTAL
Intervention: Internal biliary stent (group I, n=18)
Number of subjects: 37

Group type: COMPARATOR
Intervention: No internal biliary stent (group II, n=19)
Number of subjects: 37
Study: 8540932

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 94

Group type: COMPARATOR
Intervention: Ampicillin alone
Number of subjects: 94
Study: 2365897

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Individual therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Well-adjusted adolescents
Number of subjects: 61
Study: 363333

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg twice daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg twice daily + Chlorthalidone 50 mg daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Chlorthalidone 50 mg daily
Number of subjects: 45
Study: 31513881

Group type: EXPERIMENTAL
Intervention: 15 seconds hand antisepsis
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 seconds hand antisepsis
Number of subjects: 0
Study: 30935338

Group type: EXPERIMENTAL
Intervention: UPA lumbar mobilizations
Number of subjects: 24
Study: 27757706

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 24997025

Group type: EXPERIMENTAL
Intervention: Stainless steel brackets
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Titanium brackets
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ceramic brackets with metal slots
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Stainless steel retainers
Number of subjects: 60
Study: 23685940

Group type: EXPERIMENTAL
Intervention: TVR plus PEG‐IFN‐α2a‐ribavirin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo plus PEG‐IFN‐α2a‐ribavirin
Number of subjects: 62
Study: 22001172

Group type: EXPERIMENTAL
Intervention: VLCD + exercise
Number of subjects: 27

Group type: COMPARATOR
Intervention: VLCD only
Number of subjects: 27
Study: 19778981

Group type: EXPERIMENTAL
Intervention: Exercise and education
Number of subjects: 98

Group type: COMPARATOR
Intervention: Education only
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual physical therapy
Number of subjects: 98
Study: 16710853

Group type: EXPERIMENTAL
Intervention: OFC (olanzapine/fluoxetine combination)
Number of subjects: 483

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 483

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 483

Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: OFC (at end point)
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: OFC (subgroup analysis)
Number of subjects: 483
Study: 15261700

Group type: EXPERIMENTAL
Intervention: Real TMS at 1 Hz and 80% of motor threshold over left temporo-parietal cortex
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Real TMS
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Second treatments (real or sham)
Number of subjects: 16
Study: 12577356

Group type: EXPERIMENTAL
Intervention: Astragalus injection (AI)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 136

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 136
Study: 9204358

Group type: EXPERIMENTAL
Intervention: Iopentol (Imagopaque 350 mg I/ml)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Diatrizoate (Urografin 370 mg I/ml)
Number of subjects: 79
Study: 8043624

Group type: EXPERIMENTAL
Intervention: Young adults (mean age = 25.2 years)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Young-old adults (mean age = 66.0 years)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Old adults (mean age = 74.7 years)
Number of subjects: 3
Study: 2927976

Group type: EXPERIMENTAL
Intervention: Bennett‐Twin nebulizer (output 0.31 ml/min, nebulization time 1 min)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Wright nebulizer (output 0.15 ml/min, nebulization time 2 min)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Wright nebulizer driven by a flow rate of 12 L/min (output 0.30 ml/min, nebulization time 1 min)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Wright nebulizer driven by a flow rate of 7 L/min (output 0.15 ml/min, nebulization time 2 min)
Number of subjects: 32
Study: 29294970

Group type: EXPERIMENTAL
Intervention: CA + ICDP + VC
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: CA + ICDP
Number of subjects: 176

Group type: COMPARATOR
Intervention: CA
Number of subjects: 176
Study: 31885071

Group type: EXPERIMENTAL
Intervention: RBC transfusion at a Hb threshold of 7 g/dl
Number of subjects: 998

Group type: COMPARATOR
Intervention: RBC transfusion at a Hb threshold of 9 g/dl
Number of subjects: 998
Study: 30908336

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 23138

Group type: COMPARATOR
Intervention: Sham-acupuncture control
Number of subjects: 23138

Group type: COMPARATOR
Intervention: Non-acupuncture control
Number of subjects: 23138
Study: 28264612

Group type: EXPERIMENTAL
Intervention: Ingenol disoxate 0.018% gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ingenol disoxate 0.012% gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ingenol disoxate 0.006% gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 26262712

Group type: EXPERIMENTAL
Intervention: Fish oil plus vitamin E
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 23800705

Group type: EXPERIMENTAL
Intervention: Children with ADHD
Number of subjects: 59

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 59
Study: 21806518

Group type: EXPERIMENTAL
Intervention: Integrated cognitive behaviour therapy and motivational interviewing (CBT/MI) delivered by a therapist
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Integrated CBT/MI delivered by computer (clinician-assisted computerised [CAC] treatment)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Person-centred therapy (PCT) - control group
Number of subjects: 274
Study: 19329193

Group type: EXPERIMENTAL
Intervention: Daytime intravenous glucocorticoid treatment
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nighttime intravenous glucocorticoid treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Both treatment protocols
Number of subjects: 35
Study: 16886837

Group type: EXPERIMENTAL
Intervention: Sarpogrelate 200 mg bid
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Sarpogrelate 200 mg tid
Number of subjects: 364

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 364
Study: 15236142

Group type: EXPERIMENTAL
Intervention: Nebulized adrenaline (3 mg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Nebulized terbutaline (5 mg)
Number of subjects: 38
Study: 11740299

Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) from 0 to -60 mm Hg in exercise-trained females (ET)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) in exercise-trained females (ET+syncope)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Lower body negative pressure (LBNP) in untrained females (UT)
Number of subjects: 49
Study: 9413965

Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasonography
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Spectral Doppler analysis
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Colour Doppler patterns
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Colour Doppler parameters
Number of subjects: 113
Study: 8422235

Group type: EXPERIMENTAL
Intervention: Electric currents of 10-20 mA for 10-20 min with 1% mepivacaine or lidocaine with epinephrine
Number of subjects: 28

Group type: COMPARATOR
Intervention: No drugs or a current of reverse polarity applied
Number of subjects: 28

Group type: COMPARATOR
Intervention: Electric currents (3.5-5.0 mA) applied for 20 min to 10 solutions in cadaveric bladders
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ionized dyes applied to cadaveric bladders
Number of subjects: 28